Biorelate
PrivateLast Round
Series A
Nov 29, 2022
Total Funding Raised
$8.98M
Company Overview
Biorelate is a biotechnology company that provides an AI-driven platform called Galactic AI™ for biomedical data curation to accelerate drug discovery and research.
Sector
AI, Data & Cloud Infrastructure
Verticals
Drug Discovery, Medical AI, Biotechnology, NLP & Conversational AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biorelate Comparables
Compare Biorelate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Causaly | 88% | |
| ONTOFORCE | 83% | |
| Data4Cure, Inc. | 81% | |
Biorelate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 29, 2022 | ||||
| Grant | Feb 4, 2019 | ||||
| Seed | Sep 18, 2018 |
Biorelate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Triple Point Ventures | Series A |
| Innovate UK | Grant |
| YFM Equity Partners | Series A |
| Catapult Ventures | Seed |
| Maven Capital Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 29, 2022
$8M round led by Maven Capital Partners and YFM Equity Partners.
- Feb 4, 2019
Secured $263K in grant funding from Innovate UK.
Biorelate Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biorelate's valuation, stock price, and market status.